Evidence map›Paper›PMID 37170155›Full record

ArticleChinese medicine2023

Bushen-Yizhi formula ameliorates mitochondrial dysfunction and oxidative stress via AMPK/Sirt1 signaling pathway in D-gal-induced aging rats.

Yanfang Liao, Yiyi Lai, Huilin Xu, Li Gao, Xiaomei Fu, Xue Wang, Qi Wang, Jiangang Shen, Jiansong Fang, Shuhuan Fang

Open access · goldAbstract read
In one paragraph

Article in Chinese medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Proteomic Analysis ofAntibiotics (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Yanfang LiaoScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.
Yiyi LaiScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.
Huilin XuScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.
Li GaoModern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan, 030006, People's Republic of China.
Xiaomei FuScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.
Xue WangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.
Qi WangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.
Jiangang ShenSchool of Chinese Medicine, the University of Hong Kong, Hong Kong S.A.R, People's Republic of China.
Jiansong FangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China. fangjs@gzucm.edu.cn.ORCID http://orcid.org/0000-0002-6998-5384
Shuhuan FangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China. fangshuhuan@gzucm.edu.cn.
Guangzhou University of Chinese Medicine · CNChinese University of Hong Kong · HKShanxi University · CN

Funding

Guangdong Province Science and Technology Plan International Cooperation Project No.2020A0505100052National Natural Science Foundation of China No.82074278Natural Science Foundation of Guangdong Province for Distinguished Young Scholars No.2022A1515011645Special Foundation of Guangdong Educational Committee No.2021KTSCX022Special Foundation of Guangdong Educational Committee No:2021ZDZX2001
6 · The paper itself

Abstract

backgroundAs a major risk factor for neurodegenerative diseases, aging has become a heavy health care burden worldwide. Age-related decline in mitochondrial function and oxidative stress is strongly associated with neurodegeneration. The previous study demonstrated that Bushen-Yizhi formula (BSYZ), a traditional Chinese medicine formula, is effective in reducing neurodegeneration.

methodsThis study is the first to investigate the effect of BSYZ on D-gal-induced learning memory in rats. Secondly, the potential metabolic mechanism of BSYZ was explored by

resultsOur data showed that BSYZ increased aspartate and betaine levels, while decreasing choline levels. Furthermore, BSYZ also increased the proteins level of CHDH and BHMT to regulate choline metabolic pathway. Meanwhile, BSYZ alleviated mitochondrial damage and oxidative stress, including enhanced ATP production and the ratio of NAD

conclusionBSYZ treatment effectively rescues neurobehavioral impairment by improving mitochondrial dysfunction, oxidative stress, neuroinflammation and neuroapoptosis via AMPK/SIRT1 pathway in D-gal-induced aging.

Indexed as

AMPK/Sirt1 signalingBushen-Yizhi formulaD-galactose-induced-aging ratsInflammationMetabolomicsMitochondrial dysfunctionNeurodegenerationOxidative stress

Identifiers

PMID37170155
PMCPMC10176912
OpenAlexW4376134664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.